CORRESP Filing
Bionano Genomics, Inc.
Date: Sept. 11, 2025 · CIK: 0001411690 · Accession: 0001140361-25-034703
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290187
Letter
Re:
BIONANO GENOMICS, INC. 9540 Towne Centre Drive, Suite 100 San Diego, CA 92121
VIA EDGAR
September 11, 2025
Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Conlon Danberg
Bionano Genomics, Inc.
Registration Statement on Form S-1 (File No. 333-290187)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Bionano Genomics, Inc. (the “ Company ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “ Registration Statement ”) so that the Registration Statement will be declared effective as of 9:00 a.m. Eastern time, on September 15, 2025, or as soon as practicable thereafter. The Company hereby authorizes David S. Wolpa or Rakesh Gopalan, both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Wolpa at (704) 916-2375 or Mr. Gopalan at (704) 916-2374.
Thank you for your assistance in this matter.
Very truly yours,
Bionano Genomics, Inc.
Show Raw Text
CORRESP 1 filename1.htm BIONANO GENOMICS, INC. 9540 Towne Centre Drive, Suite 100 San Diego, CA 92121 VIA EDGAR September 11, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Conlon Danberg Re: Bionano Genomics, Inc. Registration Statement on Form S-1 (File No. 333-290187) Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Bionano Genomics, Inc. (the “ Company ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “ Registration Statement ”) so that the Registration Statement will be declared effective as of 9:00 a.m. Eastern time, on September 15, 2025, or as soon as practicable thereafter. The Company hereby authorizes David S. Wolpa or Rakesh Gopalan, both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Wolpa at (704) 916-2375 or Mr. Gopalan at (704) 916-2374. Thank you for your assistance in this matter. Very truly yours, Bionano Genomics, Inc. /s/ R. Erik Holmlin, Ph.D. Name: R. Erik Holmlin, Ph.D. Title: President and Chief Executive Officer cc (via email): Jonathan Dixon, Bionano Genomics, Inc. David S. Wolpa, Troutman Pepper Locke LLP Rakesh Gopalan, Troutman Pepper Locke LLP